Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.96B | 5.62B | 5.14B | 5.32B | 4.84B | Gross Profit |
5.95B | 5.61B | 5.12B | 5.32B | 4.84B | EBIT |
5.28B | 4.95B | 365.64M | 657.70M | -124.66M | EBITDA |
1.26B | 542.42M | 374.56M | 778.19M | 11.71M | Net Income Common Stockholders |
1.08B | 376.29M | 223.08M | 618.61M | -116.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.92B | 5.31B | 12.15B | 13.19B | 13.11B | Total Assets |
32.52B | 30.25B | 27.60B | 27.37B | 25.88B | Total Debt |
1.49B | 1.52B | 1.50B | 1.43B | 1.45B | Net Debt |
-655.30M | 569.13M | 744.86M | 585.89M | 547.13M | Total Liabilities |
26.43B | 24.99B | 22.96B | 21.96B | 20.58B | Stockholders Equity |
6.09B | 5.26B | 4.64B | 5.41B | 5.30B |
Cash Flow | Free Cash Flow | |||
1.84B | 1.26B | 655.39M | 1.08B | 298.84M | Operating Cash Flow |
1.84B | 1.26B | 692.22M | 1.11B | 343.50M | Investing Cash Flow |
280.45M | -855.61M | -655.80M | -1.11B | 489.92M | Financing Cash Flow |
-417.29M | -202.37M | -149.62M | -186.09M | -908.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $7.31B | 7.44 | 19.06% | 1.89% | 6.10% | 206.71% | |
82 Outperform | $5.62B | 13.33 | 16.03% | 2.24% | 4.07% | 1110.92% | |
75 Outperform | $10.52B | 11.89 | 20.33% | 2.40% | 6.91% | 4.97% | |
75 Outperform | $7.02B | 20.46 | 23.56% | 0.76% | 18.31% | 13.13% | |
75 Outperform | $5.23B | 26.65 | 6.82% | 1.69% | 15.35% | -44.64% | |
68 Neutral | $4.40B | 19.02 | 5.22% | 0.06% | 2.48% | -54.02% | |
64 Neutral | $13.37B | 9.30 | 9.39% | 4.85% | 16.11% | -8.85% |
AXIS Capital announced a loss portfolio transfer reinsurance agreement with Enstar Group, retroceding $2.3 billion of reinsurance segment reserves as part of its strategy to focus on specialty insurance. This transaction, expected to close in the first half of 2025 pending regulatory approval, allows AXIS to align its balance sheet with its strategic priorities, potentially benefiting shareholders with an estimated $60 million gain over several years.